Group items tagged

British scientists said on Thursday (December 30) they would be studying whether higher doses of a cheap and widely used steroid called dexamethasone could work better for patients with severe Covid-19 compared to the standard low doses. Last year, the same scientists conducting the large trial, dubbed RECOVERY, showed that dexamethasone was able to save the lives of Covid-19 patients in what was called a "major breakthrough" in the coronavirus pandemic. They had found that a 6 mg daily dose of dexamethasone, which is used to reduce inflammation in diseases such as arthritis, cut death rates by around a third among the most severely ill Covid-19 patients in hospitals. "Given how quickly the Omicron variant is spreading, we can expect to see patients admitted to hospital with severe Covid-19 for a while to come," said Peter Horby, an Oxford University professor co-leading the trial.

Smoking increases the risk of developing schizophrenia and depression, a report by academics from the University of Bristol published on 20 June claims. It says smoking raises the risk of developing schizophrenia by between 53 per cent and 127 per cent and the risk of developing depression by from 54 per cent to 132 per cent. The authors of the report say more research is needed to identify why this is the case and that more evidence is needed to understand its impact on other mental health conditions such as anxiety or bipolar disorder. The evidence, presented at the Royal College of Psychiatrist's international congress, has been shared with the government which is currently developing a new Tobacco Control Plan for publication later this year. Action on Smoking and Health (ASH) said: "Rates of smoking are much higher among people with mental health conditions than those without, and among England's six million smokers there are an estimated 230k smokers with severe mental illness (e.g., schizophrenia and bi-polar disorder) and 1.6 million with depression and anxiety."

Are you suffering from ingrown toenail? Try it! You can easily correct your ingrown toenail at home.

The Pharmacists' Defence Association (PDA) has undertaken an additional survey of pharmacists employed in the NHS, before deciding to hold their first-ever ballot for industrial action. The PDA has more than 7,000 NHS-employed pharmacists in membership and the union is actively considering balloting those members regarding strike action. The association said: "The experience of some other unions has shown that the government's restrictive rules, designed to make it difficult for working people to lawfully take industrial action, means trade unions should test members' strength of feeling before balloting." "Trade unions are not only forced to rely upon postal ballots, but for lawful industrial action to be taken, the result must also meet three tests- at least 50% of eligible voters must vote; at least 40% of eligible voters must vote 'yes' and a majority of votes must be for 'yes'." The association is asking members in England, Northern Ireland and, Wales to show if their collective wish, insignificant enough strength, is for strike action. PDA has emailed the survey to all its members in the NHS in the three nations and will close on Tuesday 3 January.

About 540 million people worldwide are affected by back pain at any time. It is predicted that 4 in 10 office workers will undergo lower back pain inflammation. Current non-surgical treatments for back pain conditions are neither effective nor safe. As a non-toxic natural product, curcumin in turmeric has a premium anti-inflammatory profile that reduces back pain and inflammation. Radicular back pain is one of the common causes of lower back pain. Researchers observed that curcumin alleviates radiculopathy.

This neurological condition can leave you in bed for days! Researchers have discovered that curcumin for migraines is an alternative natural remedy that instantly reduces inflammation in the brain by protecting cells from free radicle damage. Neurogenic inflammation has a crucial role in migraine, and curcumin is a renowned herbal compound that has anti-inflammatory effects against suppressing this neuro-inflammation.

FlowForce Max is an innovative, natural and effective way to address your prostate problems, while adding your energy, libido, and vitality. An impeccably cured personal mix of precisely named plants and minerals, crafted and mixed to complement one another into an important prostate supporting formula. Produced in FDA- approved, GMP- certified installations, each bottle of this nutritive supplement comes with 30 tablets. So, if you follow the instructions given by the manufacturers, it also claims to be an each-natural, GMO-free supplement.

What is Red Boost? Red Boost the Most Potent, Fast-Acting Formula for Boosting Male Sexual Performance. It helps to healthy blood flow support, enhanced smooth muscle function, emotional, long- lasting performances in the bedroom and strong sexual desire all while boosting natural reserves of energy and sex drive all day long Key Feature of Red Boost reviews Boosting Male Sexual Performance Healthy blood flow support Enhanced smooth muscle function Increased Sex Drive Further Energy and Vitality Easier Weight Loss and lower jones A Sharper and Healthier Recall Increased Performances and Youthful Stamina for your Love Life Support Healthy Blood Pressure Support Healthy Blood Sugar Supporting a Healthy Immune System

American pharmaceutical giant Pfizer has received marketing authorisation from the Medicines and Healthcare products Regulatory Agency (MHRA) for its medication Etrasimod, marketed as Velsipity, used to treat people with moderately to severely active ulcerative colitis. Ulcerative colitis (UC) is a type of inflammatory bowel disease (IBD) that causes inflammation and ulcers (sores) in the lining of the large intestine (colon) and rectum. The approved recommended dose for Velsipity is one 2 mg tablet to be taken once daily. For the first three days, it is advised to take the medication with food, and subsequently, it can be taken daily either with or without food. According to the regulator, the approval of the medication is based on evidence from two clinical studies, which showed that 26 per cent of patients taking etrasimod achieved clinical remission after 12 weeks of treatment compared with 11 per cent of those receiving placebo. The studies included more than 740 patients aged 16 years and over for whom standard treatment or other treatments did not work well enough or could not be used.